KUPINSKY STUART sold (to issuer) 6,977 shares of MRCY

KUPINSKY STUART (EVP, CLO & Corp Sec) sold (to issuer) 6,977 shares of MERCURY SYSTEMS INC (MRCY) on 2026-08-14.

Original reporting
SEC EDGAR · KUPINSKY STUART
Published Aug 18, 2026, 10:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 18, 2026, 11:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MRCY
Neutral
low confidence
Mentioned
$MRCY
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MRCYNeutralLow
01

Why it matters

The newest fact is the reported sale of 6,977 shares by an EVP to the issuer on 2026-08-14, with no disclosed price and no pre-arranged 10b5-1 plan indicated.

02

Market read

Traders may note insider selling activity, but the filing provides no disclosed valuation or fundamental catalyst.

03

What to watch

Insider sales to issuer can be tied to compensation mechanics, tax planning, or share repurchase participation, so directionality is ambiguous without additional filings or context.

Relevance 3/10Novelty 3/10Timing: filed 2026-08-18 after-hours; reflects 2026-08-14 transaction

Background

This is an SEC Form 4 insider transaction disclosure for Mercury Systems, reported via EDGAR.

Company-level read

Ticker impact

$MRCYNeutralLow confidence
Context

Mercury Systems Form 4 shows EVP Stuart Kupinsky sold 6,977 shares to the issuer on 2026-08-14, price undisclosed.

Expected impact

Low likelihood of a sustained price move based solely on this filing.

Evidence & confidence

The filing is a Form 4 insider transaction without disclosed price or value, and it does not include new company fundamentals or guidance.

Market effects

No clear sector read-through from a single insider sale without disclosed transaction value.

None indicated.

None indicated.

Counterpoint

Absence of a stated 10b5-1 plan could be interpreted as less mechanical selling, but the sale is still to the issuer and lacks disclosed price/value.

Key entities

  • MERCURY SYSTEMS INC

    US-listed company whose insider transaction is disclosed on Form 4.

  • KUPINSKY STUART

    EVP, CLO & Corporate Secretary who sold 6,977 shares to the issuer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MRCYHighAI 8/10

Mercury Systems earnings analysis: questions answered and next catalysts

Mercury Systems (MRCY) reported Q1 2027 earnings with adjusted EPS of $0.52, beating estimates by 73%, and revenue of $253.0M, up 12.4% organically. The stock rose 5% to $83.58 post-earnings and is now at $87.25. Management raised FY2027 targets, including revenue approaching $1.1B and adjusted EBITDA of ~$210M. Key questions remain around cash flow, margin durability, and supply chain bottlenecks.

$MRCYHighAI 8/10

Mercury Systems (MRCY) Q1 2027 Earnings Call Transcript

Mercury Systems (MRCY) reported Q1 FY '27 record bookings ($370M, +48% YoY), revenue ($253M), and adjusted EBITDA ($56M). The company raised its FY '27 outlook, expecting double-digit revenue growth and $1.1B in total revenue. Key growth drivers include increased production volumes and defense spending tailwinds. The company also highlighted progress in margin expansion and free cash flow conversion.

$MRCYHighAI 8/10

Why is Mercury Systems stock rallying today?

Mercury Systems (MRCY) stock rose 3.8% after reporting fiscal Q1 earnings that surpassed estimates, with adjusted EPS of $0.52 vs. $0.30 and revenue of $253M vs. $245M. JPMorgan upgraded the stock to Overweight with a $102 target, citing strong bookings and backlog growth. Piper Sandler reiterated its Overweight rating with a $107 target. The company's record Q1 bookings of $370M and a total backlog of $2.1B highlighted robust defense demand.

$MRCYMed

JPMorgan upgrades this aerospace stock after earnings beat

JPMorgan upgraded Mercury Systems (MRCY) to overweight, citing strong Q1 earnings and revenue beats. The bank lowered its price target to $102 but sees 22% upside. Mercury raised its full-year adjusted EBITDA and revenue growth outlook, with a 35.2% gross margin, the highest since Q2 2023, according to JPMorgan.